![Seth Fischer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Seth Fischer
Directeur/Membre du Conseil chez
MILESTONE PHARMACEUTICALS INC.
Fortune : 441 402 $ au 31/05/2026
Profil
Mr. Seth H.
Fischer is an Independent Non-Executive Director at Milestone Pharmaceuticals, Inc., an Independent Director at Esperion Therapeutics, Inc. and an Advisor at Healthquest Capital Management Co LLC.
He is on the Board of Directors at Milestone Pharmaceuticals, Inc. and Esperion Therapeutics, Inc. Mr. Fischer was previously employed as an Independent Director by Marinus Pharmaceuticals, Inc., a Lead Independent Director by Agile Therapeutics, Inc., a Chief Executive Officer & Director by VIVUS, Inc., a Group Chairman by Biosense Webster, Inc., a Chairman-Worldwide Franchise by Cordis Corp., a Group Chairman by North American Pharmaceuticals Co., a Chairman & President by Ortho-McNeil Pharmaceutical, Inc., a Group Chairman by Johnson & Johnson, a Chairman by Janssen Pharmaceuticals, Inc., and a Chairman by Scios, Inc. He also served on the board at Spectrum Pharmaceuticals, Inc., BioSig Technologies, Inc. and Trius Therapeutics, Inc. He received his undergraduate degree from The Ohio University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/05/2026 | 141 023 ( 0,05 % ) | 441 402 $ | 31/05/2026 | |
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Seth Fischer
| Sociétés | Poste | Début |
|---|---|---|
| ESPERION THERAPEUTICS, INC. | Directeur/Membre du Conseil | 28/10/2021 |
| MILESTONE PHARMACEUTICALS INC. | Directeur/Membre du Conseil | 21/03/2023 |
Healthquest Capital Management Co LLC
 Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital invests in companies located in the United States. The firm focuses on services, healthcare IT, medical devices, diagnostics and pharma services. It participates in growth stage transactions with an investment size of USD 20 - 100 million. The firm also makes co-investments and acts as a lead investor. | Consultant / Advisor | - |
Anciens postes connus de Seth Fischer
| Sociétés | Poste | Fin |
|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 11/02/2025 |
| AGILE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 26/08/2024 |
| SPECTRUM PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 31/07/2023 |
| STREAMEX CORP. | Directeur/Membre du Conseil | 17/05/2019 |
| VIVUS, INC. | Directeur Général | 31/12/2017 |
Formation de Seth Fischer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
90
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Cordis Corp.
 Cordis Corp. Medical SpecialtiesHealth Technology Develops and manufactures high-quality cardiovascular & endovascular medical devices | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes next-generation therapies | Health Technology |
Spectrum Pharmaceuticals, Inc.
 Spectrum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel and targeted oncology & hematology drug products | Health Technology |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Agile Therapeutics, Inc.
 Agile Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures hormonal contraceptive products | Health Technology |
Marinus Pharmaceuticals, Inc.
 Marinus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for rare genetic epilepsies and other seizure disorders | Health Technology |
Milestone Pharmaceuticals, Inc.
 Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
BioSig Technologies, Inc.
 BioSig Technologies, Inc. Investment Banks/BrokersFinance Operates as an asset tokenization company that provides blockchain technology to tokenize gold and commodities | Finance |
Ortho-McNeil Pharmaceutical LLC
 Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Ohio University
 The Ohio University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biosense Webster, Inc.
 Biosense Webster, Inc. Medical SpecialtiesHealth Technology Provides diagnostic and therapeutic catheters | Health Technology |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
North American Pharmaceuticals Co. | |
Healthquest Capital Management Co LLC
Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital invests in companies located in the United States. The firm focuses on services, healthcare IT, medical devices, diagnostics and pharma services. It participates in growth stage transactions with an investment size of USD 20 - 100 million. The firm also makes co-investments and acts as a lead investor. | Finance |
